The approval comes two months after Jascayd (nerandomilast) was approved for idiopathic pulmonary fibrosis.

Sunscreen remains essential for skin health, despite recent controversies. Experts emphasize proper use and broad-spectrum protection to prevent skin cancer.

MHE has a conversation with Renuka Iyer, M.D., who became CMO of NCCN in early December. Iyer is aiming to enhance evidence-based cancer care and expand guidelines for rare cancers and diverse populations.

University of Florida researchers found immune systems destroy single beta cells before attacking larger pancreatic islets, explaining Type 1 diabetes progression and why younger patients lose cells more aggressively.

Winter exacerbates atopic dermatitis in children, but effective management strategies and new treatments offer hope for improved skin health and comfort.

Here’s what you missed this week on Managed Healthcare Executive.

Discover groundbreaking advancements in dermatology from the 2025 Fall Clinical Conference, featuring innovative treatments for psoriasis, alopecia, and atopic dermatitis.

Pfizer’s sigvotatug vedotin combined with Keytruda is being studied in patients with non-small cell lung cancer. Researchers suggest sigvotatug vedotin’s ability to induce immunogenic cell death may enhance antitumor activity.

To gain approvals, biosimilar manufacturers could do faster, less expensive analytical studies of their products' composition.